Altimmune Expands License Agreement With Janssen Vaccines to Include COVID-19 - (Fidelity via NewsPoints Desk)

  • Altimmune has amended an agreement with Johnson & Johnson, expanding the number of licenses covered under the pact to include COVID-19, as reported by Fidelity.

  • As part of the deal, Altimmune has agreed to pay additional development-based milestones of up to about $1.2 million.

  • It also agreed to "pay royalty payments as a percentage of net sales of products for the treatment or prevention of COVID-19 in any country where the manufacture of such product is covered."

To read more NewsPoints articles, click here.